Literature DB >> 12714400

Retention of corneal epithelial cells following Goldmann tonometry: implications for CJD risk.

R Lim1, B Dhillon, K M Kurian, P A Aspinall, K Fernie, J W Ironside.   

Abstract

AIMS: To assess the adequacy of current decontamination methods for the Goldmann tonometer in the context of variant Creutzfeldt-Jakob disease (vCJD).
METHODS: Reusable Goldmann tonometer prisms were used to perform applanation tonometry on different groups of patients. Following tonometry, retained materials were collected from the tonometer prism head and examined using cytological methods. The used tonometers were subjected to a series of conditions to evaluate their effect on the residual cell numbers found on the tonometer heads. These included wiping alone and wiping or washing followed by disinfection of the tonometer prism. The effect on cell counts of drying the prism overnight was studied, as well as drying overnight and then wiping and disinfecting. All disinfections were performed with sodium hypochlorite (0.05% w/v).
RESULTS: The cytology specimens of 69 patients were studied. Patients using eye drops regularly desquamated significantly more corneal epithelial cells with Goldmann tonometry than patients not using regular eye drops. The mean number of cells was 156 (range 0-470) for patients using eye drops and 14 (4-57) for patients not using eye drops (p = 0.004). Wiping or washing the tonometer head reduced the cell number significantly but neither method completely eliminated cells. The two methods were not significantly different (p=0.3). Drying left a large number of cells (23-320 cells).
CONCLUSIONS: Retained corneal epithelial cells, following the standard decontamination routine of tonometer prisms, may represent potential prion infectivity. Manual cleaning was the most important step in reducing epithelial cell retention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714400      PMCID: PMC1771634          DOI: 10.1136/bjo.87.5.583

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors.

Authors:  I Zerr; J P Brandel; C Masullo; D Wientjens; R de Silva; M Zeidler; E Granieri; S Sampaolo; C van Duijn; N Delasnerie-Lauprêtre; R Will; S Poser
Journal:  J Clin Epidemiol       Date:  2000-07       Impact factor: 6.437

2.  Abnormal diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease following corneal transplantations.

Authors:  Alejandro A Rabinstein; Michelle L Whiteman; Robert T Shebert
Journal:  Arch Neurol       Date:  2002-04

Review 3.  Creutzfeldt-Jakob disease and the eye. I. Background and patient management.

Authors:  C J Lueck; G G McIlwaine; M Zeidler
Journal:  Eye (Lond)       Date:  2000-06       Impact factor: 3.775

Review 4.  Possible iatrogenic transmission of Creutzfeldt-Jakob disease via tonometer tips: a review of the literature.

Authors:  J S Walia; C L Chronister
Journal:  Optometry       Date:  2001-10

Review 5.  Inactivation of transmissible degenerative encephalopathy agents: A review.

Authors:  D M Taylor
Journal:  Vet J       Date:  2000-01       Impact factor: 2.688

6.  Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization.

Authors:  W A Rutala; D J Weber
Journal:  Clin Infect Dis       Date:  2001-04-10       Impact factor: 9.079

7.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.

Authors:  J D Wadsworth; S Joiner; A F Hill; T A Campbell; M Desbruslais; P J Luthert; J Collinge
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

8.  Experimental creutzfeldt-jakob disease transmitted via the eye with infected cornea.

Authors:  E E Manuelidis; J N Angelo; E J Gorgacz; J H Kim; L Manuelidis
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

9.  Transmissible mink encephalopathy: infectivity of corneal epithelium.

Authors:  R F Marsh; R P Hanson
Journal:  Science       Date:  1975-02-21       Impact factor: 47.728

Review 10.  Iatrogenic Creutzfeldt-Jakob disease at the millennium.

Authors:  P Brown; M Preece; J P Brandel; T Sato; L McShane; I Zerr; A Fletcher; R G Will; M Pocchiari; N R Cashman; J H d'Aignaux; L Cervenáková; J Fradkin; L B Schonberger; S J Collins
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

View more
  4 in total

1.  Variant CJD and tonometry.

Authors:  J S Mehta; R J Osborne; P A Bloom
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

2.  Ocular Tonometry and Sporadic Creutzfeldt - Jakob Disease (sCJD): A Confirmatory Case-Control Study.

Authors:  Zoreh Davanipour; Eugene Sobel; Argyrios Ziogas; Carey Smoak; Thomas Bohr; Keith Doram; Boleslaw Liwnicz
Journal:  Br J Med Med Res       Date:  2014-04-30

Review 3.  A Systematic Review Regarding Tonometry and the Transmission of Infectious Diseases.

Authors:  Nicole Atkins; William Hodge; Bruce Li
Journal:  J Clin Med Res       Date:  2018-01-26

4.  Prion Seeds Distribute throughout the Eyes of Sporadic Creutzfeldt-Jakob Disease Patients.

Authors:  Christina D Orrù; Katrin Soldau; Christian Cordano; Jorge Llibre-Guerra; Ari J Green; Henry Sanchez; Bradley R Groveman; Steven D Edland; Jiri G Safar; Jonathan H Lin; Byron Caughey; Michael D Geschwind; Christina J Sigurdson
Journal:  mBio       Date:  2018-11-20       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.